reference/20164925

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20164925

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1431
issn	1556-0864
issueIdentifier	9
pageRange	1423-1431
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	1423
bibliographicCitation	Duruisseaux M, Baudrin L, Quoix E, Wislez M, Moro-Sibilot D, Coëtmeur D, Monnet I, Mourlanette P, Morère JF, Soria JC, Westeel V, Morin F, Cadranel J. Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial. J Thorac Oncol. 2012 Sep;7(9):1423–31. doi: 10.1097/jto.0b013e31825ab897. PMID: 22767177.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0c353fd60a7971f1a1a944ffec7858f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a568715c6ba618a3ab8d703c972e4b7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edac47b759d2bae893eb793e2759ed90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00359f4dea2659383ce72344ae64ce6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c2e75fbf230b322562a797a6d350937 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e05dbae976d05e2b75abbd1ab90f47be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a21a24bbb00710dd7eff30d4894d529b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_197e9aea0d239b7b5e2c5004a9a32c27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52bbb7b8dd2d9dcbae57bc6bba0d0c1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c5ad01442ac1c01955604f77fdd6105 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91dc128f5ee3b55133c64b7a3b5432ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8746e03db963aeb81b367fe81fb1df5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7518-7859 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1495-0966 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ad5a3ccbb10a92a6a4b19d0a13e128f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6776-8610
date	201209
identifier	https://pubmed.ncbi.nlm.nih.gov/22767177 https://doi.org/10.1097/jto.0b013e31825ab897
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311 https://portal.issn.org/resource/ISSN/1556-0864
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Chemotherapy Effectiveness After First-Line Gefitinib Treatment for Advanced Lepidic Predominant Adenocarcinoma (Formerly Advanced Bronchioloalveolar Carcinoma): Exploratory Analysis of the IFCT-0401 Trial
discusses	http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0024707 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0005997
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002282Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D002288Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D016879
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D002289Q000556 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D002282Q000556 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D002282Q000401 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D002288Q000556 http://id.nlm.nih.gov/mesh/D002288Q000401 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D000077156 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016190Q000008 http://id.nlm.nih.gov/mesh/D000068437
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7161 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_da2a9e97ef6a043914c06f326d163747 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851

Total number of triples: 89.